Kyowa Hakko Bio Co., Ltd.


Kyowa Hakko Bio Co., Ltd. (KHB) is a world pioneer in creating new technologies with a mission to solve the world’s issues with fermentation technology.

KHB has developed the world's first industrial fermentation process to produce L-glutamic acid in 1956, leading decades of breakthroughs in microbial breeding and large-scale bio-production.

For years in the industry, KHB has been a worldwide provider of pharmaceutical grade and nutritional ingredients with reliable quality, stable supply, and strong technical support.

KHB’s headquarters is located in Yamaguchi Japan, where its main production base also lies. But (it) has expanded its global reach in the United States (USA), Europe, and other parts of the world, delivering Japanese standard specialty compounds.

KHB prides itself of an array of functional raw ingredients strongly backed by scientific evidence and clinical studies, of outstanding caliber or trait that abides to their strict purity measures under their umbrella Kyowa Quality assurance program.

Which is why it is renowned to be trusted by global pharmaceutical and supplement companies, regardless of scale.

Inspire. Innovate. Transform.

Improving Lives with Health Science

Kirin Holdings Co, Ltd.


Kirin Holdings Company, Limited is a major Japanese food, beverage, and pharmaceutical conglomerate headquartered in Tokyo, Japan. Best known for iconic alcoholic products like Kirin Ichiban beer, the group operates across multiple global sectors including alcoholic drinks, soft beverages, and health sciences.

Year 2008, Kyowa Hakko Bio was originally established taking over the bio-chemical business following a strategic alliance and partial integration between the Kirin Group and Kyowa Hakko Group. Then in 2019, Kirin Holdings announced the board resolution to acquire a 95% controlling stake. Later that same year, the acquisition was officially completed, making Kyowa Hakko Bio a direct subsidiary of Kirin Holdings. And in January 2023; Kyowa Hakko Bio became a 100% wholly owned subsidiary of Kirin Holdings.

Some information and graphic assets are grabbed from the official site of this product. This page is purely for promotion and information sharing; no infringement is intended.

Credits to the rightful owner.

PRODUCTS FROM OUR PARTNER:

Kyowa Hakko Bio Co., Ltd.

a subsidiary of

Kirin Holdings

Setria® L-Glutathione Reduced

Cognizin® Citicoline

Immuse® LC-Plasma Postbiotics

Let’s Collaborate!

We’d love to hear from you.

Contact Us